About ImmuneOncia Therapeutics Inc.
ImmuneOncia was established as a joint venture between Sorrento Therapeutics, USA and Yuhan Corporation, Korea, focusing on immuno-oncology and aims to bring safe, effective immunotherapies to patients worldwide.
State of Ownership
Business Development Executive, Nature Publishing Group
Sales Account Executive, Springer Nature
Business Development Executive, Nature Publishing Group, Springer Nature